Overview Financials News + Filings Key Docs Charts Ownership Insiders |
|
CSB Bancorp, Inc. (CSBB)
|
Add to portfolio |
|
|
|
| Price: |
$37.75
| | Metrics |
| OS: |
2.68
|
M
| |
|
|
| Market cap: |
$101
|
M
| |
|
|
|
|
|
| |
|
|
|
|
|
| | | |
| | | | | |
| TTM Valuation | | | |
|
|
|
| |
|
|
|
|
|
| |
|
|
| EPS |
| |
|
|
|
BVPS
|
$37.36
| |
1.01
|
x P/B
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-05-22 | Jun-30-22 | Dec-31-21 | Dec-05-21 | Jun-30-21 | Dec-31-20 | Dec-31-19 |
| Revenues | 4.0 | 40.7 | 18.2 | 38.9 | 35.2 | 17.3 | 35.1 | 33.8 |
| Revenue growth | -89.8% | 15.8% | 5.1% | 10.8% | | | 3.7% | 12.0% |
| Cost of goods sold | 0.0 | 14.4 | 6.6 | 13.6 | 13.4 | 6.1 | 12.7 | 12.5 |
| Gross profit | 4.0 | 26.3 | 11.6 | 25.2 | 21.8 | 11.2 | 22.4 | 21.3 |
| Gross margin | 100.0% | 64.6% | 63.9% | 64.9% | 61.8% | 64.9% | 63.9% | 63.1% |
| Selling, general and administrative | 0.4 | 1.9 | 1.0 | 0.7 | 1.7 | 0.9 | 1.1 | 1.1 |
| Sales and marketing | | | | | | | 0.4 | 0.5 |
| EBITA | -0.4 | 21.4 | 8.8 | 24.6 | 16.7 | 8.5 | 21.4 | 20.2 |
| EBITA margin | -10.2% | 52.6% | 48.3% | 63.2% | 47.5% | 48.8% | 60.9% | 59.8% |
| Amortization of intangibles | | | | 0.0 | | | 0.1 | 0.1 |
| EBIT | -0.4 | 21.4 | 8.8 | 24.5 | 16.7 | 8.5 | 21.3 | 20.2 |
| EBIT margin | -10.2% | 52.6% | 48.3% | 63.1% | 47.5% | 48.8% | 60.7% | 59.6% |
| Pre-tax income | 3.5 | 16.5 | 7.3 | 13.4 | 13.4 | 7.0 | 13.1 | 12.9 |
| Income taxes | -9.8 | 3.2 | 1.4 | 2.6 | 2.6 | 1.3 | 2.5 | 2.5 |
| Tax rate | | 19.5% | 19.3% | 19.2% | 19.2% | 19.3% | 19.3% | 19.4% |
| Net income | 13.3 | 13.3 | 5.9 | 10.8 | 10.8 | 5.6 | 10.6 | 10.4 |
| Net margin | 336.7% | 32.7% | 32.5% | 27.9% | 30.8% | 32.5% | 30.1% | 30.8% |
| |
| Diluted EPS | | $4.91 | $2.17 | $3.97 | $3.97 | $2.05 | $3.85 | $3.80 |
| Shares outstanding (diluted) | | 2.7 | 2.7 | 2.7 | 2.7 | 2.7 | 2.7 | 2.7 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|